BRCA2 and posterior cortical atrophy: In a study of 1878 PCa patients (70% EA men) undergoing PCa multigene panel testing, the rate of BRCA1 and BRCA2 mutations was 4.6%, and the rate of mutations of the DNA MMR genes was 2.8% [34], supporting the genetic testing approach for hereditary PCa.